The Holland Sentinel Subscription Offers, Specials, and Discounts

Yet another major home goods retailer is apparently feeling a cash crunch as the popular Texas-based At Home is reportedly set to file for Chapter 11 bankruptcy.

At Home, which reportedly operates 260 stores across 40 states, has been dealing with a difficult financial situation that has been made worse by US tariffs and uncertain global trade policies.

Bloomberg reported that the company missed an interest payment on May 15, and entered a forbearance deal with its lenders that gives it relief from creditor action through June 30.

At Home said it is “actively collaborating with our financial stakeholders and have put forbearance agreements in place with respect to certain interest payments under the company’s debt instruments,” in a statement to Bloomsburg.

For At Home fans, there is some potential good news in the company’s statement, too.

“These agreements provide us flexibility as we continue to take steps to position At Home for near and long-term success,” the company told Bloomberg.

So, while that is not a definitive answer to the question of whether stores will end up closing, it certainly appears as though the goal is to keep At Home going.

Tariffs are reportedly an issue for the chain because it sources a lot of its merchandise from China. However, it has reportedly been making efforts since 2024 to source its items from outside of that country.

Bankruptcy would allow At Home to for a plan to repay creditors or it could choose to sell stores to pay debt.

  • Related Posts

    Two cases of attempted murders in 12hrs in city | Nagpur News – Times of India

    NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV)…

    Estranged Husband’s Lawyer Found Guilty of Interfering in Jennifer Dulos Murder Case

    NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)…

    Leave a Reply

    Your email address will not be published. Required fields are marked *